Class IV Heart Failure Patients Almost Included In MCAC Coverage Vote

Medtronic anticipates October completion of its Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), with results to be presented at the American College of Cardiology meeting in spring 2004

More from Archive

More from Medtech Insight